Rationale for using irreversible EGFR Inhibitors in...

  • Main
  • 2019 / 03
  • Rationale for using irreversible EGFR Inhibitors in...
Molecular Pharmacology 2019 / 03

Rationale for using irreversible EGFR Inhibitors in combination with PI3K inhibitors for advanced Head and Neck Squamous Cell Carcinoma

Michmerhuizen, Nicole L., Leonard, Elizabeth, Matovina, Chloe, Harris, Micah, Herbst, Gabrielle, Kulkarni, Aditi, Zhai, Jingyi, Jiang, Hui, Carey, Thomas E., Brenner, Chad
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Molecular Pharmacology
DOI:
10.1124/mol.118.115162
Date:
March, 2019
File:
PDF, 3.58 MB
2019
Conversion to is in progress
Conversion to is failed